Euglycemic diabetic ketoacidosis (EuDKA) is a rare but serious complication of sodium-glucose cotransporter 2 (SGLT2) inhibitors, characterized by metabolic acidosis with near-normal blood glucose levels, making it challenging to diagnose. The gene discussed is SLC5A2; the disease is metabolic acidosis.